Abstract: A leg cover for stacking cylindrical tanks includes: a body for fitting over and accommodating a pair of legs supporting one of the cylindrical tanks, the body having a base with two opposing planar ground contact surfaces capable of contact with a ground surface on which the cylindrical tank rests when the cover is in use and two opposing curved surfaces disposed inwardly from each of the ground contact surfaces thereof, the two opposing curved surfaces each having curvatures for conforming with the curvature of a top surface of another of the cylindrical tanks. A leg cover has planar ground contact surfaces and includes a plurality of cavities formed in a base of the cover so that a series of grooves are formed in the ground contact surfaces, thereby providing traction to the contact surfaces.

Abstract: Systems and methods for updating software on vehicles are provided. A method for performing a software update on a vehicle includes using a preference of a person of authority over the vehicle as to when to issue a request for an authorization to perform the software update on the vehicle. When the software update is available for the vehicle, the method includes issuing the request for the authorization to perform the software update on the vehicle in accordance with the preference of the person of authority over the vehicle. After receiving the authorization to perform the software update, the method includes initiating the software update on the vehicle.

Abstract: The present invention provides improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of the therapeutic, prophylactic or diagnostic agent as compared to formulations known in the art. The improved pharmaceutical formulations of the invention for administration to the respiratory system of a patient for the treatment of a variety of disease conditions comprise a mass of biocompatible particles comprising an active agent, and a hydrogenated starch hydrosylate (HSH). The improvement over the prior art comprises the presence of HSH in the pharmaceutical formulation. The invention further relates to a method of treating diseases comprising administering the pharmaceutical formulations of the present invention to the respiratory system of a patient in need of treatment.

Abstract: Disclosed is a tank foot ring comprising: a body for supporting a pressurized tank made of polymeric material; and the body having an open end enclosing a hollow space or spaces on which a bottom portion of the pressurized tank rests and wherein the open end is in air flow communication with such hollow space or spaces, and an opposing surface for contacting a ground surface on which the foot ring rests. The opposing surface has a series of openings for drainage of water from the hollow space or spaces. Further provided is a collar for mounting on a top portion of a pressurized tank. The collar comprises: a body, a fastening system and a rotatable lid disposed on the collar. Further provided is a collar with a window cut-out for viewing tank data and a regulator mounting clip for securing a regulator of the tank in place during use.

Abstract: The present invention provides improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of the therapeutic, prophylactic or diagnostic agent as compared to formulations known in the art. The improved pharmaceutical formulations of the invention for administration to the respiratory system of a patient for the treatment of a variety of disease conditions comprise a mass of biocompatible particles comprising an active agent, and a hydrogenated starch hydrosylate (HSH). The improvement over the prior art comprises the presence of HSH in the pharmaceutical formulation. The invention further relates to a method of treating diseases comprising administering the pharmaceutical formulations of the present invention to the respiratory system of a patient in need of treatment.

Abstract: The present invention pertains to interferon-beta (IFN-beta) compositions comprising interferon-beta and a grafted poly(glutamic acid) polymer having an average molecular weight between 26,000 and 40,000 g/mol, grafted with alpha-tocopherol substituents, the average molar grafting ratio being 4.5-5.5 moles %, the weight/weight ratio between said grafted poly(glutamic acid) polymer and IFN-beta being between 24 and 125. The present invention also pertains to the preparation methods of such compositions and their application to obtain therapeutic compositions in dosage unit form delivering IFN-beta over an extended period of time.

Abstract: Apparatus for alert notification, the apparatus comprising: a power mode detector, configured to detect a predefined change in a power mode of a mobile phone, and an alert notifier, associated with the power mode detector and configured to notify a predefined user about an alert condition the detected predefined change in the power mode is indicative of.

Abstract: The present invention provides improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of the therapeutic, prophylactic or diagnostic agent as compared to formulations known in the art. The improved pharmaceutical formulations of the invention for administration to the respiratory system of a patient for the treatment of a variety of disease conditions comprise a mass of biocompatible particles comprising an active agent, and a hydrogenated starch hydrosylate (HSH). The improvement over the prior art comprises the presence of HSH in the pharmaceutical formulation. The invention further relates to a method of treating diseases comprising administering the pharmaceutical formulations of the present invention to the respiratory system of a patient in need of treatment.

Abstract: The present invention pertains to interferon-beta (IFN-beta) compositions comprising interferon-beta and a grafted poly(glutamic acid) polymer having an average molecular weight between 26,000 and 40,000 g/mol, grafted with alpha-tocopherol substituents, the average molar grafting ratio being 4.5-5.5 moles %, the weight/weight ratio between said grafted poly(glutamic acid) polymer and IFN-beta being between 24 and 125. The present invention also pertains to the preparation methods of such compositions and their application to obtain therapeutic compositions in dosage unit form delivering IFN-beta over an extended period of time.

Abstract: The present invention provides improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of the therapeutic, prophylactic or diagnostic agent as compared to formulations known in the art. The improved pharmaceutical formulations of the invention for administration to the respiratory system of a patient for the treatment of a variety of disease conditions comprise a mass of biocompatible particles comprising an active agent, and a hydrogenated starch hydrosylate (HSH). The improvement over the prior art comprises the presence of HSH in the pharmaceutical formulation. The invention further relates to a method of treating diseases comprising administering the pharmaceutical formulations of the present invention to the respiratory system of a patient in need of treatment.

Abstract: Apparatus for alert notification, the apparatus comprising: a power mode detector, configured to detect a predefined change in a power mode of a mobile phone, and an alert notifier, associated with the power mode detector and configured to notify a predefined user about an alert condition the detected predefined change in the power mode is indicative of.

Abstract: A sampling dish, comprising a body defining a cavity and comprising a bottom wall, an open top end and side walls extending from the bottom wall to the open top end; and a removable closure element comprising a ring and a plate, the ring being movable into a mating position with edges of the side walls of the body to secure securing said plate in place over the open top of the body, thereby ensuring hermeticity of the dish in a closed position, and the ring being removable from the mating position to allow removal of the plate from the open top of the body for access to the cavity of the dish in an open position.

Abstract: A knee rehabilitation device for assisting in the movement of a leg has a longitudinal bar and a lower and upper leg engaging bar. The lower leg engaging bar extends perpendicular from the longitudinal bar and is for engaging the leg of the user. The upper leg engaging bar is carried by the longitudinal bar and is for engaging the leg of the user. The device has a base portion secured to the longitudinal bar. The base portion has rotatable devices for movement of the device relative to a surface. A handle is connected to the longitudinal portion. The handle has a hand engaging portion for the user to engage to facilitate movement of the device. The hand engaging portion projects from the extension portion and is generally parallel to the pivot location and the pair of leg engaging bars. The leg of the user below the knee engages both the lower leg engaging bar and the upper leg engaging bar.

Abstract: The present invention relates a novel heat exchange system. More particularly, the invention concerns a heat exchange system for use in bathing apparatus, including showers, bathtubs and whirlpools. Advantageously, this system is simple to install, maintain and clean and can easily be integrated in a limitless variety of bathing apparatus.

Abstract: The present invention provides improved pharmaceutical formulations for pulmonary delivery having improved chemical and physical stability of the therapeutic, prophylactic or diagnostic agent as compared to formulations known in the art. The improved pharmaceutical formulations of the invention for administration to the respiratory system of a patient for the treatment of a variety of disease conditions comprise a mass of biocompatible particles comprising an active agent, and a hydrogenated starch hydrosylate (HSH). The improvement over the prior art comprises the presence of HSH in the pharmaceutical formulation. The invention further relates to a method of treating diseases comprising administering the pharmaceutical formulations of the present invention to the respiratory system of a patient in need of treatment.

Abstract: A flush valve leakage prevention device for a toilet tank is disclosed. The device comprises a closer portion adapted to be in resilient contact with the flapper portion of the flush valve and an attachment portion adapted to be attached to the toilet tank. The attachment portion is adapted to be attached in a position which allows the closer portion to remain in at least partial resilient contact with the valve flapper portion, and, in the absence or an external force from a flush actuating system of the toilet tank, to hold down said flapper portion to improve the seal between the valve seat and the flapper portion of the valve.

Abstract: A biological specimen cassette comprising a base and a lid wherein the lid is pivotally mounted relative to the base. The lid so pivots into the base that, once in a closed position, the lid is included within the base thereby providing to the cassette, an overall thickness which is equal to that of the base. Similarly, the lid has a tab which does not extend beyond the dimensions of the base.

Abstract: A brake wear managing system is disclosed herein. The brake wear managing system comprises a plurality of sensor assemblies, an on-board controller and, optionally, a remote controller. The sensor assembly includes a mounting assembly and a sensor to measure the wear of a brake assembly and to generate a signal accordingly. Each sensor is coupled to the on-board controller. The on-board controller is configured to generate brake wear condition signals in response to the signal generated by each sensor. The optional remote controller is directly connected to the on-board controller or coupled to it via a wireless communication signal. The remote controller is configured to be operated either in maintenance mode or in operational mode.